
Abdel A. Mohamed
Examiner (ID: 6501)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1653, 1806, 1811, 1654, 1815, 1611, 1803 |
| Total Applications | 1048 |
| Issued Applications | 680 |
| Pending Applications | 109 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 655183
[patent_doc_number] => 07109299
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-19
[patent_title] => 'Peptides and compounds that bind to the IL-5 receptor'
[patent_app_type] => utility
[patent_app_number] => 10/168372
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 18803
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168372 | Peptides and compounds that bind to the IL-5 receptor | Dec 15, 1999 | Issued |
Array
(
[id] => 1534835
[patent_doc_number] => 06489290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-03
[patent_title] => 'Antiplatelet agent'
[patent_app_type] => B2
[patent_app_number] => 09/381261
[patent_app_country] => US
[patent_app_date] => 1999-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12595
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489290.pdf
[firstpage_image] =>[orig_patent_app_number] => 09381261
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381261 | Antiplatelet agent | Dec 6, 1999 | Issued |
Array
(
[id] => 1342404
[patent_doc_number] => 06586402
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'LH-RH peptide analogues, their uses and pharmaceutical compositions containing them'
[patent_app_type] => B1
[patent_app_number] => 09/450443
[patent_app_country] => US
[patent_app_date] => 1999-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14346
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586402.pdf
[firstpage_image] =>[orig_patent_app_number] => 09450443
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/450443 | LH-RH peptide analogues, their uses and pharmaceutical compositions containing them | Nov 29, 1999 | Issued |
Array
(
[id] => 1446798
[patent_doc_number] => 06369030
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Inhibitors of histone acetyltransferases (HATs) and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/451034
[patent_app_country] => US
[patent_app_date] => 1999-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 7787
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369030.pdf
[firstpage_image] =>[orig_patent_app_number] => 09451034
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/451034 | Inhibitors of histone acetyltransferases (HATs) and uses thereof | Nov 28, 1999 | Issued |
Array
(
[id] => 1534842
[patent_doc_number] => 06489292
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Stable aqueous insulin preparations without phenol and cresol'
[patent_app_type] => B1
[patent_app_number] => 09/441702
[patent_app_country] => US
[patent_app_date] => 1999-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4076
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09441702
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/441702 | Stable aqueous insulin preparations without phenol and cresol | Nov 15, 1999 | Issued |
Array
(
[id] => 1521719
[patent_doc_number] => 06414123
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Method for purifying FSH'
[patent_app_type] => B1
[patent_app_number] => 09/442132
[patent_app_country] => US
[patent_app_date] => 1999-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11539
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/414/06414123.pdf
[firstpage_image] =>[orig_patent_app_number] => 09442132
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442132 | Method for purifying FSH | Nov 15, 1999 | Issued |
Array
(
[id] => 1467197
[patent_doc_number] => 06458760
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Method for treating tissue damaged from ischemia'
[patent_app_type] => B1
[patent_app_number] => 09/439705
[patent_app_country] => US
[patent_app_date] => 1999-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11576
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458760.pdf
[firstpage_image] =>[orig_patent_app_number] => 09439705
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/439705 | Method for treating tissue damaged from ischemia | Nov 11, 1999 | Issued |
Array
(
[id] => 4087268
[patent_doc_number] => 06162904
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Manufacturing method for intraveneously administrable immune globulin and resultant product'
[patent_app_type] => 1
[patent_app_number] => 9/421405
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7142
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162904.pdf
[firstpage_image] =>[orig_patent_app_number] => 421405
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421405 | Manufacturing method for intraveneously administrable immune globulin and resultant product | Oct 20, 1999 | Issued |
Array
(
[id] => 1470153
[patent_doc_number] => 06407068
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells'
[patent_app_type] => B1
[patent_app_number] => 09/421162
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6166
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407068.pdf
[firstpage_image] =>[orig_patent_app_number] => 09421162
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421162 | Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells | Oct 18, 1999 | Issued |
Array
(
[id] => 1495403
[patent_doc_number] => 06403564
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection'
[patent_app_type] => B1
[patent_app_number] => 09/417884
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15213
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403564.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417884
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417884 | Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection | Oct 13, 1999 | Issued |
Array
(
[id] => 6861190
[patent_doc_number] => 20030092198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'SITE-SPECIFIC LABELING OF DISULFIDE-CONTAINING TARGETING VECTORS'
[patent_app_type] => new
[patent_app_number] => 09/417109
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8579
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092198.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417109
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417109 | Site-specific labeling of disulfide-containing targeting vectors | Oct 12, 1999 | Issued |
Array
(
[id] => 1333465
[patent_doc_number] => 06596728
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use'
[patent_app_type] => B1
[patent_app_number] => 09/410083
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10626
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 753
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596728.pdf
[firstpage_image] =>[orig_patent_app_number] => 09410083
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410083 | Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use | Sep 30, 1999 | Issued |
Array
(
[id] => 4411504
[patent_doc_number] => 06300470
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Antibiotic cryptdin peptides and methods of their use'
[patent_app_type] => 1
[patent_app_number] => 9/397386
[patent_app_country] => US
[patent_app_date] => 1999-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 40
[patent_no_of_words] => 18389
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300470.pdf
[firstpage_image] =>[orig_patent_app_number] => 397386
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397386 | Antibiotic cryptdin peptides and methods of their use | Sep 14, 1999 | Issued |
Array
(
[id] => 4087139
[patent_doc_number] => 06162895
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Peracylated insulin compositions and process for making the same'
[patent_app_type] => 1
[patent_app_number] => 9/392416
[patent_app_country] => US
[patent_app_date] => 1999-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2070
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162895.pdf
[firstpage_image] =>[orig_patent_app_number] => 392416
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/392416 | Peracylated insulin compositions and process for making the same | Sep 8, 1999 | Issued |
| 09/390275 | METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN AP2 INHIBITOR AND COMBINATION | Sep 6, 1999 | Abandoned |
Array
(
[id] => 1467206
[patent_doc_number] => 06458764
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'GRF analogs with increased biological potency'
[patent_app_type] => B1
[patent_app_number] => 09/389486
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14612
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458764.pdf
[firstpage_image] =>[orig_patent_app_number] => 09389486
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/389486 | GRF analogs with increased biological potency | Sep 2, 1999 | Issued |
Array
(
[id] => 4359274
[patent_doc_number] => 06191112
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Human therapeutic uses of BPI protein products'
[patent_app_type] => 1
[patent_app_number] => 9/388758
[patent_app_country] => US
[patent_app_date] => 1999-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12856
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/191/06191112.pdf
[firstpage_image] =>[orig_patent_app_number] => 388758
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/388758 | Human therapeutic uses of BPI protein products | Sep 1, 1999 | Issued |
| 09/147897 | METHODS AND DEVICES FOR PREPARING PROTEIN CONCENTRATES | Aug 29, 1999 | Abandoned |
Array
(
[id] => 1068898
[patent_doc_number] => 06844424
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-18
[patent_title] => 'Method for obtaining avian biological products'
[patent_app_type] => utility
[patent_app_number] => 09/763724
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1301
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844424.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763724
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763724 | Method for obtaining avian biological products | Aug 26, 1999 | Issued |
Array
(
[id] => 7013964
[patent_doc_number] => 20010051146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-13
[patent_title] => 'AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE'
[patent_app_type] => new
[patent_app_number] => 09/180599
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4432
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20010051146.pdf
[firstpage_image] =>[orig_patent_app_number] => 09180599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/180599 | AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE | Aug 26, 1999 | Abandoned |